Z-0864-2023 Class II Ongoing

Recalled by Biomerieux Inc — Hazelwood, MO

FDA device recall Z-0864-2023 was initiated by Biomerieux Inc on Nov 9, 2022 and is designated Class II. Reason for recall: As the temperature and time out of range was exceeded, product performances cannot be guaranteed The recall status is ongoing. Affected quantity: 4 units.

Recall Details

Product Type
Devices
Report Date
Jan 11, 2023
Initiation Date
Nov 9, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4 units

Product Description

VIDAS CLINICAL VIDAS HCG 60 TESTS, CATALOG 30405-01

Reason for Recall

As the temperature and time out of range was exceeded, product performances cannot be guaranteed

Distribution Pattern

US Nationwide distribution.

Code Information

UDI/DI 03573026156923, Batch Numbers: 1009527770

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0864-2023
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 24, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.